VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_15-vv-00089
Package ID: USCOURTS-cofc-1_15-vv-00089
Petitioner: Jacqueline Haim
Filed: 2015-01-29
Decided: 2025-02-24
Vaccine: hepatitis A; human papillomavirus (HPV); meningococcal (Menactra)
Vaccination date: 2013-07-19
Condition: multiple sclerosis (MS)
Outcome: compensated
Award amount USD: 20000

AI-assisted case summary:
On January 29, 2015, Jacqueline Haim filed a Vaccine Program petition after receiving hepatitis A, human papillomavirus (HPV), and meningococcal meningitis (Menactra) vaccines on July 19, 2013. She alleged that those vaccinations caused or significantly aggravated multiple sclerosis and that residual effects lasted more than six months.

The public decision was entered on a joint stipulation after a long-running case. It identifies the vaccines, the alleged multiple sclerosis theory, and the settlement terms, but it does not describe symptom onset, diagnostic studies, treatment, expert reports, or the litigation history in detail. Respondent denied that Haim's alleged MS or residual effects were caused in fact or significantly aggravated by the hepatitis A, HPV, or Menactra vaccines, and denied that those vaccines caused any other injury or her current condition.

The parties filed a joint stipulation on February 24, 2025. Special Master Mindy Michaels Roth adopted it the same day and awarded a lump sum of $20,000.00, to be paid by ACH to counsel's IOLTA account for prompt disbursement to Jacqueline Haim. The amount represented all damages available under section 15(a). Haim was represented by Alexander Laufer of Eisenhower and Laufer, PC.

Theory of causation field:
Hepatitis A, HPV, and meningococcal/Menactra vaccines (July 19, 2013; concurrent) alleged to cause or significantly aggravate multiple sclerosis with residual effects for more than six months. COMPENSATED by joint stipulation. Respondent denied causation-in-fact/significant aggravation and denied that the vaccines caused any other injury or current condition; public stipulation gives limited clinical facts despite long docket. Special Master Mindy Michaels Roth adopted the stipulation on February 24, 2025. Award: $20,000.00 ACH to counsel IOLTA for prompt disbursement to Jacqueline Haim. Attorney: Alexander Laufer, Eisenhower and Laufer, PC, Fairfax, VA.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_15-vv-00089-1
Date issued/filed: 2025-03-24
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 2/24/2025) regarding 204 DECISION Stipulation. Signed by Special Master Mindy Michaels Roth. (dkj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 15-89V
Filed: February 24, 2025
* * * * * * * * * * * * *
JACQUELINE HAIM, *
*
Petitioner, *
*
*
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * *
Alexander Laufer, Esq., Eisenhower and Laufer, PC, Fairfax, VA, for petitioner.
Mary E. Holmes, Esq., US Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On January 29, 2015, Jacqueline Haim (“petitioner”) filed a petition for compensation
under the National Vaccine Injury Compensation Program.2 Petitioner alleges that she developed
multiple sclerosis (“MS”) after receiving Hepatitis A (“Hep A”), human papillomavirus (“HPV”),
and meningococcal meningitis vaccines on July 19, 2013. Stipulation, filed February 24, 2025, at
¶¶ 1-4. Respondent denies that any of the aforementioned immunizations caused petitioner’s
injury. Stipulation at ¶ 6.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In accordance
with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information,
the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that
the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2018).
1

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 2 of 7
Nevertheless, the parties have agreed to settle the case. On February 24, 2025, the parties
filed a joint stipulation agreeing to settle this case and describing the settlement terms.
Respondent agrees to issue the following payment:
A lump sum of $20,000.00 to be paid through an ACH deposit to petitioner’s
counsel’s IOLTA account for prompt disbursement to petitioner, Jacqueline
Haim. This amount represents compensation for all damages that would be available
under § 300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount and
on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance
with this decision.3
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.
2

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
JACQUELINE HAIM, )
)
Petitioner, )
) No. 15-89V
v. ) Special Master Roth
) ECF
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Respondent. )
)
STIPULATION
The parties hereby stipulate to the following matters:
1. Jacqueline Haim, petitioner, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the “Vaccine
Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt
of hepatitis A, human papillomavirus (HPV), and/or meningococcal (Menactra) vaccines, which
vaccines are contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3 (a).
2. Petitioner received her hepatitis A, HPV, and Menactra vaccinations on July 19, 2013.
3. The vaccinations were administered within the United States.
4. Petitioner alleges that petitioner suffered from multiple sclerosis (MS) that was
caused-in-fact, or significantly aggravated, by her July 19, 2013 hepatitis A, HPV, and/or
Menactra vaccinations. Petitioner further alleges that petitioner suffered the residual effects of
the alleged injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on petitioner’s behalf as a result of the alleged injury.

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 4 of 7
6. Respondent denies that petitioner’s alleged MS or its residual effects were caused-in-
fact, or significantly aggravated, by the hepatitis A, HPV, and/or Menactra vaccines; and denies
that the hepatitis A, HPV, and/or Menactra vaccines caused petitioner any other injury or
petitioner’s current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry of judgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue
the following vaccine compensation payment:
A lump sum of $20,000.00 to be paid through an ACH deposit to petitioner’s
counsel’s IOLTA account for prompt disbursement to petitioner. This amount
represents compensation for all damages that would be available under 42 U.S.C.
§300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to 42
U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings before
the special master to award reasonable attorneys’ fees and costs incurred in proceeding upon this
petition.
10. Petitioner and petitioner’s attorney represent that compensation to be provided
pursuant to this Stipulation is not for any items or services for which the Program is not
primarily liable under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can
reasonably be expected to be made under any State compensation programs, insurance policies,
2

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 5 of 7
Federal or State health benefits programs (other than Title XIX of the Social Security Act (42
U.S.C. § 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
11. Payment made pursuant to paragraph 8 and any amounts awarded pursuant to
paragraph 9 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i), subject
to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys’ fees and litigation costs, and past unreimbursed expenses, the money provided
pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a
strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C.
§300aa-15(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in petitioner’s
individual capacity, and on behalf of petitioner’s heirs, executors, administrators, successors or
assigns, does forever irrevocably and unconditionally release, acquit and discharge the United
States and the Secretary of Health and Human Services from any and all actions or causes of
action (including agreements, judgments, claims, damages, loss of services, expenses and all
demands of whatever kind or nature) that have been brought, could have been brought, or could
be timely brought in the Court of Federal Claims, under the National Vaccine Injury
Compensation Program, 42 U.S.C. § 300aa-10 et seq., on account of, or in any way growing out
of, any and all known or unknown, suspected or unsuspected personal injuries to or death of
petitioner resulting from, or alleged to have resulted from, the hepatitis A, HPV, and/or Menactra
vaccinations administered on July 19, 2013, as alleged in a petition for vaccine compensation
filed on or about January 29, 2015, in the United States Court of Federal Claims as petition No.
15-89V.
3

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 6 of 7
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
15. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete conformity with the terms of this Stipulation, then the parties’
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the hepatitis A, HPV, and/or Menactra vaccines
caused, or significantly aggravated, petitioner’s alleged MS or any other injury or petitioner’s
current condition.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
/
/
/
/
4

Case 1:15-vv-00089-UNJ Document 208 Filed 03/24/25 Page 7 of 7